Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Brickell Biotech Inc (BBI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Brickell Biotech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.6300 -0.4400    -10.81%
09/08 - Closed. Currency in USD ( Disclaimer )
After Hours
3.5500
-0.0800
-2.2039%
19:57:14 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 179,171
  • Bid/Ask: 3.5500 / 3.6500
  • Day's Range: 3.4700 - 3.9500
Brickell Biotech 3.6300 -0.4400 -10.81%
IndustryBiotechnology
SectorHealthcare
Employees

13

Equity Type

ORD

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company engaged in developing prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases. The Company’s pipeline combines several development-stage candidates and a cutting-edge platform with autoimmune and inflammatory disorders program for the treatment of primary axillary hyperhidrosis. Its products include Cialis, Taltz, Gemzar, Prozac, Cymbalta and Juvederm. Its lead development-stage program, BBI-02, is a Phase I ready, highly selective, and orally bioavailable DYRK1A inhibitor that has demonstrated in various preclinical models, including atopic dermatitis and rheumatoid arthritis. BBI-10, the Company’s lead early-stage STING inhibitor candidate, is a novel, potent, and orally available covalent STING inhibitor that specifically targets the palmitoylation site of STING, which allows to inhibit both wild-type STING and gain-of-function mutants.

Contact Information

Top Executives

Name Age Since Title
Robert Busard Brown 59 2019 CEO & Director
Reginald L. Hardy 63 2009 Co-Founder & Chairman of the Board
Victor J. Bauer 86 - Scientific Advisor
Stacy R. Smith - 2018 Clinical Advisor
William H. Eaglstein - - Dermatology Advisor
Charles J. Betlach 78 - Drug Development Advisor
Andrew Hirschberg - - Investment Banker
Vijay B. Samant 69 2000 Independent Director
Jonathan K. Wilkin - - Member of Advisory Board
Christopher E.M. Griffiths - - Member of Advisory Board
David Michael Pariser - - Dermatology Advisor
Zoe Diana Draelos - - Member of Advisory Board
Eric Simpson - - Member of Advisory Board
Gary A. Lyons 71 1997 Independent Director
Laurie Beth Burke - - Regulatory Advisor
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BBI Comments

Write your thoughts about Brickell Biotech Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alon Oahyo
Alon Oahyo Jul 06, 2022 12:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going back to 1$?
Johny Cash
Johny Cash Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why falling it is?
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
because it's a scam
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they will put it down to 0.001
Johny Cash
Johny Cash Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
after they can to buy cheaper
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Johny Cash probably next week it will be half from today
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0.000001
Duane Goodson
Duane Goodson Jun 23, 2022 10:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
She getting ready to pop.
Cody Sutton
Cody Sutton May 04, 2022 5:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MASSIVE run incoming
Ron Welt
Ron Welt Apr 19, 2022 8:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya now let's see how it goes from here.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
grafitx esposito
grafitx esposito Jan 18, 2022 2:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MP’s initial magnetics facility in Fort Worth, Texas, will source materials from Mountain Pass, California, restoring a fully integrated U.S. supply chainMP has entered a long-term agreement with General Motors to supply U.S.-sourced and manufactured rare earth alloy and magnets to power more than a dozen models using GM’s Ultium PlatformThe facility will produce NdFeB alloy and magnets with the potential to power approximately 500,000 EV motors per year; a gradual production ramp is expected to begin in 2023
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email